Indexed with PubMed and Science Citation Index (E) 
Users online: 2600 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (509 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Tables

 Article Access Statistics
    PDF Downloaded52    
    Comments [Add]    

Recommend this journal


 Table of Contents    
Year : 2018  |  Volume : 84  |  Issue : 6  |  Page : 707-708

Authors' reply

1 Department of Dermatology and Venereology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
2 Department of Dermatology, Venereology and Leprosy, King George's Medical University, Lucknow, Uttar Pradesh, India

Date of Web Publication05-Oct-2018

Correspondence Address:
Sanjay Singh
Department of Dermatology and Venereology, Institute of Medical Sciences, Banaras Hindu University, Varanasi - 221 005, Uttar Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijdvl.IJDVL_779_18

Rights and Permissions

How to cite this article:
Singh S, Shukla P. Authors' reply. Indian J Dermatol Venereol Leprol 2018;84:707-8

How to cite this URL:
Singh S, Shukla P. Authors' reply. Indian J Dermatol Venereol Leprol [serial online] 2018 [cited 2020 Aug 13];84:707-8. Available from:


We welcome the comments on our article[1] and thank you for the opportunity to make our humble submission in reply [Table 1]. In this pragmatic study,[1] the focus was on real-life situation in view of perceived recent loss of effectiveness of terbinafine in dermatophytic infections in India. Our objective was to find the evidence for or against the above perception. The study provides evidence that yes, there is a problem, and this is how grave it is.
Table 1: Issues raised and the replies

Click here to view

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Singh S, Shukla P. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients. Indian J Dermatol Venereol Leprol 2018;84:554-7.  Back to cited text no. 1
[PUBMED]  [Full text]  
Verma SB, Vasani R. Male genital dermatophytosis—clinical features and the effects of the misuse of topical steroids and steroid combinations—an alarming problem in India. Mycoses 2016;59:606-14.  Back to cited text no. 2
Hay RJ, Ashbee HR. Fungal infections. In: Griffiths CEM, Barker J, BleikerT, Chalmers R, Creamer D, editors. Rook's Textbook of Dermatology. 9th ed. West Sussex: John Wiley and Sons; 2016. p. 32.1-32.96.  Back to cited text no. 3
Jacob R, Konnikov N. Oral antifungal agents. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's Dermatology in General Medicine. 8th ed. New York: McGraw-Hill; 2012. p. 2796-2806.  Back to cited text no. 4
Shenoy MM, Shenoy SM. Superficial fungal infections. In: Sacchidanand S, Oberai C, Inamadar AC, editors. IADVL Textbook of Dermatology. 4th ed. Mumbai: Bhalani; 2015. p. 459-516.  Back to cited text no. 5
Rajagopalan M, Inamadar A, Mittal A, Miskeen AK, Srinivas CR, Sardana K, Godse K, Patel K, Rengasamy M, Rudramurthy S, Dogra S. Expert consensus on the management of dermatophytosis in India (ECTODERM India). BMC Dermatol 2018;18:6.  Back to cited text no. 6


  [Table 1]


Print this article  Email this article


Online since 15th March '04
Published by Wolters Kluwer - Medknow